Souichi Adachi
Department Of Clinical Biostatistics/Clinical Biostatistics Course
Kyoto, Japan
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 297 publications
Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.
Journal: British journal of haematology
Published: March 25, 2026
Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.
Journal: Leukemia
Published: November 01, 2025
Clinical Characteristics and Outcomes of Acute Megakaryoblastic Leukemia With t(1;22)(p13;q13) in Children.
Journal: Pediatric blood & cancer
Published: November 01, 2025
Identification of cellular hierarchy in paediatric acute myeloid leukaemia: The Japan Children's Cancer Group trial (JCCG AML-12).
Journal: British journal of haematology
Published: September 12, 2025
Safety and efficacy of arsenic trioxide in intensification therapy for newly diagnosed childhood acute promyelocytic leukemia: results from the JPLSG AML-P13 study.
Journal: International journal of hematology
Published: March 28, 2025
Metabolic reprogramming by PRDM16 drives cytarabine resistance in acute myeloid leukemia.
Journal: Haematologica
Published: December 24, 2024
JCCG ALL-B12: Evaluation of Intensified Therapies With Vincristine/Dexamethasone Pulses and Asparaginase and Augmented High-Dose Methotrexate for Pediatric B-ALL.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 12, 2024
Real-world Outcomes of Commercial Tisagenlecleucel for Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia in Japan.
Journal: Transplantation and cellular therapy
Published: August 23, 2024
Growth retardation and adult height in pediatric patients with chronic-phase chronic myeloid leukemia treated with tyrosine kinase inhibitors.
Journal: Leukemia
Published: August 11, 2024
Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.
Journal: Haematologica
Published: July 08, 2024
Last Updated: 09/26/2026